These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19039219)

  • 1. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The Bleeding with Antithrombotic Therapy (BAT) Retrospective Study.
    Toyoda K; Yasaka M; Nagata K; Nagao T; Gotoh J; Sakamoto T; Uchiyama S; Minematsu K;
    Cerebrovasc Dis; 2009; 27(2):151-9. PubMed ID: 19039219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet agents are risk factors for cerebellar hemorrhage in patients with primary intracerebral hemorrhage.
    Matsukawa H; Shinoda M; Yamamoto D; Fujii M; Murakata A; Ishikawa R; Omata F
    J Stroke Cerebrovasc Dis; 2011; 20(4):346-51. PubMed ID: 20656513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage.
    Toyoda K; Okada Y; Minematsu K; Kamouchi M; Fujimoto S; Ibayashi S; Inoue T
    Neurology; 2005 Oct; 65(7):1000-4. PubMed ID: 16217049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location of acute brain hemorrhage in patients undergoing antithrombotic therapy.
    Itabashi R; Yasaka M; Kuwashiro T; Nakagaki H; Miyashita F; Naritomi H; Minematsu K
    J Neurol Sci; 2009 May; 280(1-2):87-9. PubMed ID: 19254798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of outcome in warfarin-related intracerebral hemorrhage.
    Zubkov AY; Mandrekar JN; Claassen DO; Manno EM; Wijdicks EF; Rabinstein AA
    Arch Neurol; 2008 Oct; 65(10):1320-5. PubMed ID: 18852345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Known knowns and known unknowns: risks associated with combination antithrombotic therapy.
    Johnson S
    Thromb Res; 2008; 123 Suppl 1():S7-11. PubMed ID: 18829070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy and predilection for cerebellar hemorrhage.
    Toyoda K; Okada Y; Ibayashi S; Inoue T; Yasumori K; Fukui D; Uwatoko T; Makihara N; Minematsu K
    Cerebrovasc Dis; 2007; 23(2-3):109-16. PubMed ID: 17124390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage.
    Rosand J; Eckman MH; Knudsen KA; Singer DE; Greenberg SM
    Arch Intern Med; 2004 Apr; 164(8):880-4. PubMed ID: 15111374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy.
    Gathier CS; Algra A; Rinkel GJ; van der Worp HB
    Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome?
    Stead LG; Jain A; Bellolio MF; Odufuye AO; Dhillon RK; Manivannan V; Gilmore RM; Rabinstein AA; Chandra R; Serrano LA; Yerragondu N; Palamari B; Decker WW
    Clin Neurol Neurosurg; 2010 May; 112(4):275-81. PubMed ID: 20042270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do the antithrombotic therapy at the time of intracerebral hemorrhage influence clinical outcome? analysis between the difference of antiplatelet and anticoagulant agents and clinical course.
    Okada T; Nakase T; Sasaki M; Ishikawa T
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1781-8. PubMed ID: 24957306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior oral antithrombotic therapy is associated with early death in patients with supratentorial intracerebral hemorrhage.
    Yamashita S; Kimura K; Iguchi Y; Shibazaki K
    Intern Med; 2011; 50(5):413-9. PubMed ID: 21372450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage.
    Caso V; Paciaroni M; Venti M; Alberti A; Palmerini F; Milia P; Billeci AM; Silvestrelli G; Biagini S; Agnelli G
    Cerebrovasc Dis; 2007; 24(2-3):215-8. PubMed ID: 17630480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic drug uses and deep intracerebral hemorrhages in stroke patients with deep cerebral microbleeds.
    Imaizumi T; Inamura S; Kohama I; Yoshifuji K; Nomura T; Komatsu K
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):869-75. PubMed ID: 22959109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study.
    Toyoda K; Yasaka M; Iwade K; Nagata K; Koretsune Y; Sakamoto T; Uchiyama S; Gotoh J; Nagao T; Yamamoto M; Takahashi JC; Minematsu K;
    Stroke; 2008 Jun; 39(6):1740-5. PubMed ID: 18388341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
    Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
    Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reported antiplatelet use influences long-term outcome independently in deep intracerebral hemorrhage.
    Kuramatsu JB; Mauer C; Kiphuth IC; Lücking H; Kloska SP; Köhrmann M; Huttner HB
    Neurosurgery; 2012 Feb; 70(2):342-50; discussion 350. PubMed ID: 21826030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of intracerebral hemorrhage under antithrombotic therapy in the warfarin era].
    Kohama M; Yoshida M; Mino M; Tominaga T
    No Shinkei Geka; 2015 Mar; 43(3):199-205. PubMed ID: 25748804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.